Pharma waits in vain for US/Korea trade deal
This article was originally published in Scrip
The US and South Korea appear no nearer to ratifying their stalled bilateral free trade agreement (FTA) than before the recent summit in Washington, DC, between the leaders of the two countries.
You may also be interested in...
Novel antibody-drug conjugate receives approval in Japan for second-line breast cancer, providing another push to Japanese firm’s strategic plan to build up its oncology operations.
Collaboration with fundraising Tokyo-based venture builds mid-sized firm's interest in cell-based therapies in a highly supportive regulatory environment.
New long-term clinical data with Takeda’s dengue vaccine contender show a durable response against all four serotypes and support the dosing regimen in an ongoing pivotal study.